{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:30:12Z","timestamp":1794475812557,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008002","name":"Vancouver Coastal Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015803","name":"British Columbia Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ygyno.2026.05.011","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:34:37Z","timestamp":1778877277000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing the essential parameters of race, ethnicity and geography in endometrial cancer and the impact on presentation, treatment and outcomes"],"prefix":"10.1016","volume":"209","author":[{"given":"Amy","family":"Jamieson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Talhouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn R.","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2026.05.011_bb0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2021.01.036","article-title":"Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019","volume":"161","author":"Gu","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.011_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/aje\/kwae178","article-title":"Trends in endometrial cancer incidence in the United States by race\/ethnicity and age of onset from 2000 to 2019","volume":"194","author":"Rodriguez","year":"2025","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2026.05.011_bb0015","author":"Commission CHR"},{"issue":"9","key":"10.1016\/j.ygyno.2026.05.011_bb0020","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/ijgc-2023-004552","article-title":"Race and ethnicity reporting in endometrial cancer literature","volume":"33","author":"Raimondo","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.05.011_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygyno.2025.06.013","article-title":"Delays, fragmentation, and desire for alternatives: a qualitative study of the patient experience through diagnosis and treatment of endometrial cancer","volume":"199","author":"Johnson","year":"2025","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.05.011_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2023.09.009","article-title":"TP53 mutation and abnormal p53 expression in endometrial cancer: associations with race and outcomes","volume":"178","author":"Whelan","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.05.011_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygyno.2022.11.015","article-title":"Racial and ethnic differences in type II endometrial cancer mortality outcomes: the contribution of sociodemographic, clinicopathologic, and treatment factors","volume":"168","author":"Karia","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.05.011_bb0040","article-title":"Increasing incidence of uterine carcinosarcoma: a United States Cancer Statistics study","volume":"40","author":"Liao","year":"2022","journal-title":"Gynecol Oncol Rep."},{"issue":"22","key":"10.1016\/j.ygyno.2026.05.011_bb0045","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers","volume":"37","author":"Clarke","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2026.05.011_bb0050","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1158\/2159-8290.CD-23-0546","article-title":"Molecular characterization of endometrial carcinomas in Black and White patients reveals disparate drivers with therapeutic implications","volume":"13","author":"Weigelt","year":"2023","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.ygyno.2026.05.011_bb0055","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/S0002-9378(97)70380-6","article-title":"Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer","volume":"176","author":"Clifford","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.011_bb0060","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1038\/s41467-024-52554-5","article-title":"An elevated rate of whole-genome duplications in cancers from Black patients","volume":"15","author":"Brown","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.011_bb0065","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"issue":"29","key":"10.1016\/j.ygyno.2026.05.011_bb0070","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.ygyno.2026.05.011_bb0075","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2026.05.011_bb0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2026.05.011_bb0085","author":"Statistics Canada"},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2026.05.011_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.AOG.0000195062.75199.7d","article-title":"Improved survival of Asians with corpus cancer compared with Whites: an analysis of underlying factors","volume":"107","author":"Zhang","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.011_bb0095","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1158\/1055-9965.EPI-21-0829","article-title":"Cancer-specific mortality in Asian American women diagnosed with gynecologic cancer: a nationwide population-based analysis","volume":"31","author":"Karia","year":"2022","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ygyno.2026.05.011_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ygyno.2023.12.023","article-title":"Uterine cancer among Asian Americans - disparities & clinical characteristics","volume":"182","author":"Johnson","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.05.011_bb0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2022.02.001","article-title":"Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2026.05.011_bb0110","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41379-022-01165-w","article-title":"Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification","volume":"35","author":"Thompson","year":"2022","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.05.011_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.011_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.51906","article-title":"Race, prevalence of POLE and POLD1 alterations, and survival among patients with endometrial cancer","volume":"7","author":"Zheng","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.ygyno.2026.05.011_bb0125","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1186\/s12885-019-6296-7","article-title":"Comparing cancer incidence, stage at diagnosis and outcomes of first nations and all other Manitobans: a retrospective analysis","volume":"19","author":"Horrill","year":"2019","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2026.05.011_bb0130","first-page":"1105","article-title":"Cancer in First Nations people living in British Columbia, Canada: an analysis of incidence and survival from 1993 to 2010","volume":"28","author":"McGahan","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"7","key":"10.1016\/j.ygyno.2026.05.011_bb0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826019888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:59:10Z","timestamp":1794473950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826019888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"alternative-id":["S0090825826019888"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.05.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the essential parameters of race, ethnicity and geography in endometrial cancer and the impact on presentation, treatment and outcomes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}